在儿科肝病中动态肝功能测试
Thora Wesenberg Helt1, Jon Nielsen2, Gabriella Ficerai-Garland3
1Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Diagnostics (Basel, Switzerland)
|March 14, 2026
概括
动态肝功能测试,内素绿色 (ICG) 清除率和肝胆膜扫描 (HBS) 在患有肝病的儿童中相对相关性很好. 这些测试为肝功能和疾病标志物提供了宝贵的见解.
科学领域:
- 儿科胃肠病学和肝病学
- 诊断成像和核医学 核医学
背景情况:
- 准确评估儿科肝功能是一个挑战.
- 传统的肝功能测试可能无法反映儿童的疾病严重程度.
- 动态测试,如氨酸绿色 (ICG) 清除率和肝胆镜 (HBS) 显示出有前途的结果.
研究的目的:
- 评估儿童肝病中ICG清除与HBS之间的相关性.
- 为了识别与ICG清除和HBS相关的肝病标志物.
- 评估动态肝功能测试对儿童的有用性.
主要方法:
- 该研究包括131名患有肝病或肝移植 (LTx) 后的儿童 (0-18岁).
- 所有参与者都接受了ICG许可和HBS评估.
- 2015年11月至2024年8月期间收集的数据.
主要成果:
- ICG 清除率和 HBS 显示了显著的相关性.
- 这两种测试都与肝损伤,胆固醇,肝硬化和门门高血压有关.
- ICG 清除与门血流有独特的相关性;LTx 影响 HBS,但不影响 ICG 清除.
结论:
- ICG清除和HBS是相关的,对于评估儿童的肝功能有价值.
- 这些动态测试与各种传统的肝功能标志物保持一致.
- 需要进一步的研究来确定ICG清除和HBS在疾病进展中的预测价值.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Pharmacokinetics in Pediatric Patients: Drug Metabolism
312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
310
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
310
Liver Physiology
4.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion
349
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Pharmacokinetics in Pediatric Patients: Drug Distribution
419
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419


